48
Participants
Start Date
December 18, 2008
Primary Completion Date
January 27, 2010
Study Completion Date
April 5, 2010
Tanezumab
15 mg IV single dose
Placebo
Placebo IV single dose
Allegheny Pain Management, Altoona
Lyndhurst Clinical Research, Winston-Salem
Lyndhurst Clinical Research, Kernersville
Greenville Hospital System University Medical Group, Department of OB/GYN, Greenville
Mount Vernon Clinical Research, Atlanta
Jacksonville Center for Clnical Research, Jacksonville
Advanced Women's Healthcare, West Palm Beach
Comprehensive Clinical Trials, LLC, West Palm Beach
Visions Clinical Research, Boynton Beach
Nature Coast Clinical Research, LLC, Crystal River
Bay Area Physicians for Women, Mobile
Springhill Medical Center, Mobile
Wilmax Clinical Research, Mobile
Whitaker's Women Care, East Ridge
ClinSearch, LLC, Chattanooga
Columbus Center for Women's Health Research, Columbus
Beyer Research - Women's Health Care Specialists, PC, Paw Paw
Radiant Research, Overland Park
Women's Healthcare Group, Overland Park
Women's Clinic of Lincoln, PC, Lincoln
Planned Parenthood of Arkansas and Eastern Oklahoma, Tulsa
Advances In Health, Inc., Houston
Allon Health Care, Houston
Old Farm Obstetrics and Gynecology, Salt Lake City
Salt Lake Research, Salt Lake City
Visions Clinical Research - Tucson, Tucson
Genesis Center for Clinical Research, San Diego
Medical Center for Clinical Research, San Diego
Women's Clinical Research Center, Seattle
N.E.C.C.R, Fall River LLC, Fall River
Lead Sponsor
Pfizer
INDUSTRY